Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models
- 17 July 2007
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 6 (4) , 473-482
- https://doi.org/10.1007/s10689-007-9150-z
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Evaluation of models to predict BRCA germline mutationsBritish Journal of Cancer, 2006
- Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancerJournal of Medical Genetics, 2006
- Assessing BRCA Carrier Probabilities in Extended FamiliesJournal of Clinical Oncology, 2006
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- The BOADICEA model of genetic susceptibility to breast and ovarian cancerBritish Journal of Cancer, 2004
- A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROJournal of Medical Genetics, 2004
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancerEuropean Journal Of Cancer, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics centerClinical Genetics, 2000